求購(gòu)“Citicoline”《 USP42-NF37 》的藥典標(biāo)準(zhǔn)一份.   [更多]

1.Title：Studies of the polymorphism of sodium valproate. (Ger.). Authors：Kleinebudde P; Thies R Publication Name：Sci.Pharm. Publication Year：1999 Keywords：Valproate Sodium/Oc Crystal/Ft Polymorphism/Ft Calorimetry/Ft X-Ray- Diffraction/Ft Analysis/Ft Crystallography/Ft Anticonvulsants/Ft Antimanics / Ft Oc / Ft Extract：2 Crystal modifications (M1 and M2) of Na valproate (NV) have been detected at RT, while a further form (M3) occurred at temperatures above 100 deg. Untreated NV, which had been recrystallized from toluene or ethyl acetate occurred as modification M1. These modifications were examined by thermoanalytical (DSC, thermogravimetry) and X-ray crystallographic methods. 2.【題名】Polymorphism of sodium valproate 【作 者】Mifsud, H.;Miguel, L.;Lavastre, V.;Maire, G. 【刊 名】Calorim. Anal. Therm. Calorimetrie et Analyse Thermique 【出版日期】1993 【卷 號(hào)】Vol.24 【頁(yè) 碼】309-312 【關(guān)鍵詞】polymorphism sodium valproate Polymorphism of sodium valproate 1069-66-5 polymorphism 【摘 要】Polymorphism anal. is of fundamental pharmaceutical importance for correct development of a drug, as it provides valuable knowledge of its biopharmaceutical and technol. aspects. Indeed, different polymorphs exhibit different phys. properties that can affect bioavailability. Polymorphism screening has been developed in the authors' lab., based on crystn. parameter variations for a given drug in soln. Sodium valproate is an anti-epileptic drug commercialized under the name Depakine. Five polymorphic forms were obtained by the screening and characterized by differential scanning calorimetry, X-ray powder diffractometry, thermogravimetry and IR spectroscopy. The relationships between these forms were examd.   [更多]

標(biāo)準(zhǔn)來(lái)源： 進(jìn)口藥品復(fù)核標(biāo)準(zhǔn)匯編2002年吸入用復(fù)方異丙托溴銨溶液　【注冊(cè)證號(hào)】 H20020433（第763頁(yè)）【英 文 名】 Compound Ipratropium Bromide Solution for Inhalation【生產(chǎn)廠商】 英國(guó)　Boehringer Ingelheim Limited【標(biāo) 準(zhǔn) 號(hào)】 JX19990360已有新版JX20100077標(biāo)準(zhǔn)，但是沒(méi)有雜質(zhì)結(jié)構(gòu)式信息，尋找老版標(biāo)準(zhǔn)是否有雜質(zhì)結(jié)構(gòu)式，要求有雜質(zhì)BA686BR、BIRT0109BR、BIRJ0416BR、BIRJ0420BR結(jié)構(gòu)式，如果沒(méi)有的話(huà)，還是就不能認(rèn)定有效哦！   [更多]

詳細(xì)情況 藥品：獸用biocid-30（商品名）消毒劑； 檢索途徑：美國(guó)或者日本獸藥審批網(wǎng)站（可以查到獸用消毒劑產(chǎn)品信息）； 具體要求：請(qǐng)寫(xiě)明具體網(wǎng)址，能夠查詢(xún)到該產(chǎn)品的信息，便交易成功； 交稿方式：直接點(diǎn)擊交稿在線(xiàn)交稿就是了，我會(huì)每天過(guò)來(lái)看的，謝謝各位藥智的戰(zhàn)友們； 提醒：在FDA動(dòng)物藥品中，可以查詢(xún)到一般動(dòng)物藥，但是查不到獸用消毒劑。   [更多]

天晴，潤(rùn)眾制藥甲磺酸伊馬替尼原料藥標(biāo)準(zhǔn)！   [更多]

Journal of General Chemistry, 1993, vol. 63, # 3.2, p. 424 - 427   [更多]

美國(guó)藥典 USP42 胞磷膽堿鈉（Citicoline Sodium）質(zhì)量標(biāo)準(zhǔn) 需要紙質(zhì)掃描版（影印版），帶有USP42和頁(yè)碼 注：該標(biāo)準(zhǔn)上不能帶有其他印刷的文字，網(wǎng)絡(luò)版不要。   [更多]

求購(gòu)吉非替尼美國(guó)藥典、歐洲藥典、日本藥典、中國(guó)進(jìn)口藥品質(zhì)量信息等   [更多]

2020/2021版   [更多]

求購(gòu)司維拉姆片進(jìn)口信息JX20150421   [更多]